Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
API In Capsule vs. The Lost Art Of Formulation Development
API-in-capsule offers a fast path for early clinical data, but it can't eliminate the need for full formulation development. Weighing the potential for higher total development time and cost is critical.
-
Tools For Efficient And Reliable Gene Therapy Manufacturing
Discover scalable strategies for overcoming AAV purification challenges, from low yield and impurity removal to serotype variability, as well as how advanced tools can streamline manufacturing.
-
Enabling The Future Of Intensified Biomanufacturing
Process intensification demands smarter orchestration, real-time analytics, and scalable automation. Discover how digital infrastructure enables synchronized, compliant, and predictive biomanufacturing.
-
Advancing Multiomics Through Intelligent Automation
Modern automation tackles hidden pipetting errors and boosts reproducibility. Discover how your lab can scale confidently, reduce rework, and accelerate multiomic workflows with built-in traceability.
-
Tackling Poor Bioavailability With Early Formulation Strategies
Poor oral bioavailability causes high clinical trial failure rates. Learn how to identify and apply the correct enabling formulation strategy early in development to de-risk your program and accelerate timelines.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
The Innovative Flow-Through Solution For Continuous Viral Inactivation
Discover how a novel flow-through incubator enables precise, scalable low-pH virus inactivation with narrow residence time distribution and high log reduction value to support continuous bioprocessing.
-
Scale-Up Of A Transient rAAV Production Process
Scalable rAAV production is achievable with a transient cell line and optimized bioreactor setup, delivering high titers and reduced impurities, now validated at 200 L scale for commercial readiness.
-
Scale-Up Of An Adherent rAAV Production Process
Fixed-bed bioreactors simplify the scale-up of viral vector production. Discover a system that bridges development and manufacturing with data confirming consistent performance across scales.
-
A Simple Method For Cell Growth Media Preparation
Explore how powder media and sterile fluid handling can reduce contamination risk and improve efficiency in viral vector production, especially for HEK293-based AAV workflows.
-
Exosome Production From hMSC Using A Fixed-Bed Bioreactor
Explore a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.
FORMULATION DEVELOPMENT SOLUTIONS
- Microcarrier Products
- Chromatography Consultation Tools For Process Intensification
- NutriCoat™ Attachment Solution
- Comprehensive ADC And Bioconjugation Services For Targeted Therapies
- 4Cell® XtraCHO Media System
- ADC And Bioconjugation Center Of Excellence
- Supel™ BioSPME 96-Pin Devices
- Serum-Free, Xeno-Free Systems For Culture And Differentiation Of hMSCs
- High-Purity Analytical Solvents: Consistent Quality For Applicants
- Molecule To Cure. Fast.
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- AES Cleanroom Technology Establishes New Office In Research Triangle Park To Support Regional Drug Manufacturing Growth
- Federal Equipment Announces Diagnostics Laboratory Equipment Auction
- How Eli Lilly's New Netherlands Drug Manufacturing Facility Strengthens Global Oral Solid Dose Supply Chains
- CDMO Codis Launches As Commercial Spray Drying And Amorphous Solid Dispersions Provider
- Eli Lilly Announces $1.2 Billion Investment To Expand Puerto Rico Manufacturing Site For Next-Gen Oral Medicines
- Apeloa Successfully Passes 20th FDA Inspection With No Action Indicated
- Tema Sinergie Acquires Majority Stake In Aseptic Filling OEM 6Bio
- Serán Bioscience Expands Commercial Manufacturing With New 100,000 Sq. Ft. Campus In Bend, Oregon
- Owen Mumford Launches EcoSafe® Safety Syringe Platform – Smarter For Budgets And Kinder To The Planet
- Follow The Map Of Pharmaceutical World With PHARMAP 2026